Northern Trust Corp Reviva Pharmaceuticals Holdings, Inc. Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 71,379 shares of RVPH stock, worth $74,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,379
Previous 56,636
26.03%
Holding current value
$74,234
Previous $97,000
30.93%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RVPH
# of Institutions
55Shares Held
7.45MCall Options Held
938KPut Options Held
40.8K-
Vanguard Group Inc Valley Forge, PA1.8MShares$1.88 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$1.6 Million0.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$676,7510.16% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$530,7420.03% of portfolio
-
Geode Capital Management, LLC Boston, MA419KShares$435,9040.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $21.3M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...